Skip to main content
. 2017 Dec 26;15(1):1–15. doi: 10.21873/cgp.20061

Figure 2. miRs -92a, -708 and -6126 inhibit integrin-related pathways of metastases in ovarian cancer. The pathways outlined lead to inhibition of FAK and actin remodeling. a5, Alpha5, integrin subunit; b1, beta1, integrin subunit; FAK-P, phosphorylated fokal adhesion kinase; FN, fibronectin; Rap 1B, ras-related protein-1B.

Figure 2